(387) Sensitivity analyses of the primary efficacy endpoint in a phase 2 randomized, placebo-controlled study of gabapentin enacarbil (GEn) in patients with neuropathic pain associated with postherpetic neuralgia (PHN).

Details

Language :

English

ISSN :

15265900

Volume :

15

Database :

Supplemental Index

Journal :

Journal of Pain

Publication Type :

Academic Journal

Accession number :

95085916

Full Text :

https://doi.org/10.1016/j.jpain.2014.01.298